The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology
Open accessAbstract
Gastrointestinal disorders, particularly severe constipation and delayed gastric emptying, are core symptoms of Parkinson's disease that affect most patients. However, the neuropathological substrate and physiological basis for this dysfunction are poorly defined. To begin to explore these phenomena in laboratory models of PD, rats were treated with either vehicle or rotenone (2.0 mg/kg, i.p.; 5 days/week) for 6-weeks. Myenteric plexus alpha-synuclein aggregate pathology and neuron loss were assessed 3-days and 6-months after the last rotenone injection. Gastrointestinal motility was assessed at 3-days, 1-month and 6-months after the last rotenone injection. Rotenone treatment caused an acute reduction in alpha-synuclein-immunoreactivity, but this was followed 6 months later by a robust increase in aggregate pathology and cytoplasmic inclusions that were similar in appearance to enteric Lewy-bodies in idiopathic PD. Rotenone-treated rats also had a moderate but permanent loss of small intestine myenteric neurons and an associated modest slowing of gastrointestinal motility 6-months after treatment. Our results suggest that a circumscribed exposure to an environmental toxicant can cause the delayed appearance of parkinsonian alpha-synuclein pathology in the enteric nervous system and an associated functional deficit in gastrointestinal motility. The rotenone model may therefore, provide a means to investigate pathogenic mechanisms and to test new therapeutic interventions into gastrointestinal dysfunction in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Self-citationOxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Braak, H., de Vos, R. A. I., Bohl, J., & Del Tredici, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.012 · Cited by 1,354
Parkinson's disease: a dual‐hit hypothesis
Hawkes, C. H., Del Tredici, K., & Braak, H. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00874.x · Cited by 1,021
Gastrointestinal dysfunction in Parkinson's disease
Pfeiffer, R. F. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00307-7 · Cited by 925
Frequency of Bowel Movements and the Future Risk of Parkinson’s Disease
Abbott, R. D., Petrovitch, H., White, L. R., Masaki, K. H., Tanner, C. M., Curb, J. D., Grandinetti, A., Blanchette, P. L., Popper, J. S., & Ross, G. W. (2001) · Neurology · doi:10.1212/wnl.57.3.456 · Cited by 839
A highly reproducible rotenone model of Parkinson's disease
Cannon, J. R., Tapias, V., Na, H. M., Honick, A. S., Drolet, R. E., & Greenamyre, J. T. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.01.016 · Cited by 795
Self-citationNon‐motor symptoms in Parkinson’s disease
Poewe, W. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02056.x · Cited by 782
Sherer, T. B., Kim, J.-H., Betarbet, R., & Greenamyre, J. T. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8072 · Cited by 708
Self-citationSherer, T. B., Betarbet, R., Stout, A. K., Lund, S., Baptista, M., Panov, A. V., Cookson, M. R., & Greenamyre, J. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07006.2002 · Cited by 581
Self-citationInvited Article: Nervous system pathology in sporadic Parkinson disease
Braak, H., & Del Tredici, K. (2008) · Neurology · doi:10.1212/01.wnl.0000312279.49272.9f · Cited by 538
Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses
Wakabayashi, K., Takahashi, H., Takeda, S., Ohama, E., & Ikuta, F. (1988) · Acta Neuropathologica · doi:10.1007/bf00687767 · Cited by 528
Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
Hald, A., & Lotharius, J. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.01.013 · Cited by 508
Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease
Zhang, Y., Dawson, V. L., & Dawson, T. M. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0319 · Cited by 407
Singaram, C., Gaumnitz, E. A., Torbey, C., Ashraf, W., Quigley, E. M. M., Sengupta, A., & Pfeiffer, R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92707-7 · Cited by 368
Wakabayashi, K., Takahashi, H., Ohama, E., & Ikuta, F. (1990) · Acta Neuropathologica · doi:10.1007/bf00294234 · Cited by 319
Li, Z. S., Schmauss, C., Cuenca, A., Ratcliffe, E., & Gershon, M. D. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4720-05.2006 · Cited by 276
Contraindicated Use of Cisapride: Impact of Food and Drug Administration Regulatory Action
Smalley, W., Shatin, D., Wysowski, D. K., Gurwitz, J., Andrade, S. E., Goodman, M., Chan, K. A., Platt, R., Schech, S. D., & Ray, W. A. (2000) · JAMA · doi:10.1001/jama.284.23.3036 · Cited by 255
Environment, Mitochondria, and Parkinson's Disease
Sherer, T. B., Betarbet, R., & Greenamyre, J. T. (2002) · The Neuroscientist · doi:10.1177/1073858402008003004 · Cited by 241
Self-citationWysowski, D. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02490-x · Cited by 240
ANDERSON, G., NOORIAN, A., TAYLOR, G., ANITHA, M., BERNHARD, D., SRINIVASAN, S., & GREENE, J. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.010 · Cited by 238
Pathological lesions in colonic biopsies during Parkinson’s disease
Lebouvier, T., Chaumette, T., Damier, P., Coron, E., Touchefeu, Y., Vrignaud, S., Naveilhan, P., Galmiche, J.-P., Bruley des Varannes, S., Derkinderen, P., et al. (2008) · Gut · doi:10.1136/gut.2008.162503 · Cited by 229
Mitochondrial dysfunction in neurodegenerative disorders
Schapira, A. H. V. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00115-7 · Cited by 209
Mastroberardino, P. G., Hoffman, E. K., Horowitz, M. P., Betarbet, R., Taylor, G., Cheng, D., Na, H. M., Gutekunst, C.-A., Gearing, M., Trojanowski, J. Q., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.02.009 · Cited by 195
Self-citationNeural control of the gastrointestinal tract: Implications for Parkinson disease
Cersosimo, M. G., & Benarroch, E. E. (2008) · Movement Disorders · doi:10.1002/mds.22051 · Cited by 188
Evaluation of α-synuclein immunohistochemical methods used by invited experts
Beach, T. G., White, C. L., Hamilton, R. L., Duda, J. E., Iwatsubo, T., Dickson, D. W., Leverenz, J. B., Roncaroli, F., Buttini, M., Hladik, C. L., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0409-8 · Cited by 182
Greene, J. G., Noorian, A. R., & Srinivasan, S. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.04.023 · Cited by 165
Natale, G., Pasquali, L., Ruggieri, S. A., Paparelli, A., & Fornai, F. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01162.x · Cited by 142
Abnormal colonic motility in mice overexpressing human wild-type α-synuclein
Wang, L., Fleming, S. M., Chesselet, M., & Taché, Y. (2008) · Neuroreport · doi:10.1097/wnr.0b013e3282ffda5e · Cited by 136
As the gut ages: Timetables for aging of innervation vary by organ in the Fischer 344 rat
Phillips, R. J., & Powley, T. L. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1182 · Cited by 126
Mitochondrial Dysfunction and Oxidative Stress in Parkinson’s Disease
Onyango, I. G. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9482-y · Cited by 108
Oxidative stress in Parkinson's disease
Schapira, A. H. V. (1995) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1995.tb01022.x · Cited by 99
Chaumette, T., Lebouvier, T., Aubert, P., Lardeux, B. R., Qin, C., Li, Q., Accary, D., Bézard, E., Varannes, S. B. D., Derkinderen, P., et al. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01226.x · Cited by 93
Tian, Y.-M., Chen, X., Luo, D.-Z., Zhang, X.-H., Xue, H., Zheng, L.-F., Yang, N., Wang, X.-M., & Zhu, J.-X. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.02.033 · Cited by 84
Murphy, E. M. A., DeFontgalland, D., Costa, M., Brookes, S. J., & Wattchow, D. A. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00843.x · Cited by 70
- Gastrointestinal Dysfunction in Parkinson’s Disease
Pfeiffer, R. F., Wszolek, Z. K., & Ebadi, M. (2012) · CRC Press eBooks · doi:10.1201/b12948-26 · Cited by 56
Unraveling the pathogenesis of Parkinson?s disease ? the contribution of monogenic forms
Bonifati, V., Oostra, B. A., & Heutink, P. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4104-1 · Cited by 53
Novartis suspends tegaserod sales at FDA’s request
Thompson, C. A. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/news070044 · Cited by 49
Mechanism and consequences of nerve cell death in Parkinson’s disease
Hirsch, É. C. (1999) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6360-3_7 · Cited by 40
Quantitative Autoradiography of Dihydrorotenone Binding to Complex I of the Electron Transport Chain
Greenamyre, J. T., Higgins, D. S., & Eller, R. V. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09431.x · Cited by 39
Self-citation
Cited by
Non-motor features of Parkinson disease
Schapira, A. H. V., Chaudhuri, K. R., & Jenner, P. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.62 · Cited by 2,053
Rotenone, Paraquat, and Parkinson’s Disease
Tanner, C. M., Kamel, F., Ross, G. W., Hoppin, J. A., Goldman, S. M., Korell, M., Marras, C., Bhudhikanok, G. S., Kasten, M., Chade, A. R., et al. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002839 · Cited by 1,475
Duty, S., & Jenner, P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01426.x · Cited by 753
Brain-Gut-Microbiota Axis in Parkinson’s Disease
Mulak, A. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i37.10609 · Cited by 583
Pan-Montojo, F., Anichtchik, O., Dening, Y., Knels, L., Pursche, S., Jung, R., Jackson, S., Gille, G., Spillantini, M. G., Reichmann, H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008762 · Cited by 524
Metadata
- Authors
- Drolet, R. E., Cannon, J. R., Montero, L., & Greenamyre, J. T.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 36
- Issue
- 1
- Pages
- 96-102
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2044388847
- Cited by
- 257
- References
- 43
- FWCI
- 9.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.